Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-5
|
Results: 5
Screening and monitoring for bladder cancer: Refining the use of NMP22
Authors:
Ponsky, LE Sharma, S Pandrangi, L Kedia, S Nelson, D Agarwal, A Zippe, CD
Citation:
Le. Ponsky et al., Screening and monitoring for bladder cancer: Refining the use of NMP22, J UROL, 166(1), 2001, pp. 75-78
NMP22: A sensitive, cost-effective test in patients at risk for bladder cancer
Authors:
Zippe, C Pandrangi, L Potts, JM Kursh, E Novick, A Agarwal, A
Citation:
C. Zippe et al., NMP22: A sensitive, cost-effective test in patients at risk for bladder cancer, ANTICANC R, 19(4A), 1999, pp. 2621-2623
NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer - Reply
Authors:
Zippe, C Pandrangi, L Agarwal, A
Citation:
C. Zippe et al., NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer - Reply, J UROL, 162(2), 1999, pp. 501-501
Exclusion criteria enhance the specificity and positive predictive value of NMP22and BTA stat
Authors:
Sharma, S Zippe, CD Pandrangi, L Nelson, D Agarwal, A
Citation:
S. Sharma et al., Exclusion criteria enhance the specificity and positive predictive value of NMP22and BTA stat, J UROL, 162(1), 1999, pp. 53-57
NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
Authors:
Zippe, C Pandrangi, L Agarwal, A
Citation:
C. Zippe et al., NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer, J UROL, 161(1), 1999, pp. 62-65
Risultati:
1-5
|